Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2150 of 2529 entries
View as:

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

Phase: N/A Priority: Normal
NCT ID: NCT01012739 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Phase: N/A Priority: Normal
NCT ID: NCT00509990 Org: User:
Start: 04/30/05 End: - Due: -

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Phase: N/A Priority: Normal
NCT ID: NCT01392469 Org: User:
Start: 04/20/11 End: 10/25/12 Due: 10/25/13

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02074982 Org: User:
Start: 02/26/14 End: 06/29/16 Due: 06/29/17

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00467545 Org: User:
Start: 04/30/07 End: 09/30/09 Due: 09/30/10

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00434447 Org: User:
Start: 12/31/06 End: - Due: -

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02684058 Org: User:
Start: 12/28/17 End: 04/28/23 Due: 04/28/24

Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01597908 Org: User:
Start: 06/04/12 End: 04/25/19 Due: 04/25/20

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00526045 Org: User:
Start: 07/31/07 End: 04/30/12 Due: 04/30/13

Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02213042 Org: User:
Start: 10/24/14 End: 06/04/20 Due: 06/04/21

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03215758 Org: User:
Start: 11/01/17 End: 07/30/19 Due: 07/30/20

Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function

Phase: N/A Priority: Normal
NCT ID: NCT00386750 Org: User:
Start: 06/30/05 End: 11/30/05 Due: 11/30/06

Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)

Phase: N/A Priority: Normal
NCT ID: NCT01634763 Org: User:
Start: 06/30/12 End: 01/31/16 Due: 01/31/17

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

Phase: N/A Priority: Normal
NCT ID: NCT05795153 Org: User:
Start: 04/05/23 End: 04/25/24 Due: 04/25/25

A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients

Phase: N/A Priority: Normal
NCT ID: NCT01735968 Org: User:
Start: 02/27/13 End: 10/19/18 Due: 10/19/19

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01456689 Org: User:
Start: 04/25/12 End: 06/05/19 Due: 06/05/20

Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00073528 Org: User:
Start: 12/09/03 End: 03/22/18 Due: 03/22/19

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT06004661 Org: User:
Start: 04/04/24 End: 10/01/26 Due: 10/01/27

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT01923168 Org: User:
Start: 03/11/14 End: 07/08/17 Due: 07/08/18

A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01299701 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

Phase: N/A Priority: Normal
NCT ID: NCT01148797 Org: User:
Start: 12/31/10 End: - Due: -

A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT05155709 Org: User:
Start: 05/17/22 End: 04/17/24 Due: 04/17/25

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT01700270 Org: User:
Start: 05/31/13 End: 08/31/14 Due: 08/31/15

Adjuvant Dabrafenib and Trametinib Treatment in Patients With Completely Resected High-risk Stage III Melanoma.

Phase: N/A Priority: Normal
NCT ID: NCT04961619 Org: User:
Start: 12/01/21 End: 12/05/24 Due: 12/05/25

PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01613950 Org: User:
Start: 12/31/12 End: 03/31/14 Due: 03/31/15